US Broker Ratings

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Market with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with its expansive product portfolio..

Biogen Inc. (BIIB) Stock Analysis: Navigating Healthcare with Strategic Collaborations and a 7.29% Upside

Biogen Inc. (BIIB), a prominent player in the healthcare sector, continues to be a compelling focus for investors who are keen on the pharmaceutical industry’s potential..

Prestige Consumer Healthcare (PBH) Stock Analysis: Strong Buy Ratings Signal Nearly 20% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a prominent player in the healthcare sector, specifically within the drug manufacturers’ niche focusing on specialty and generic products...

Krystal Biotech, Inc. (KRYS) Investor Outlook: Navigating a Promising Biotech Landscape with a Strong Buy Consensus

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, with a market capitalization of $8.1 billion. This Pittsburgh-based company has positioned itself as..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Powerhouse with 30.88% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leading player in the healthcare diagnostics and research industry, stands as a compelling investment opportunity for those looking to capitalize on..

Zimmer Biomet Holdings (ZBH) Stock Analysis: Potential 18% Upside in a Competitive Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a significant player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of..

West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 49.58% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a current..

Sanofi (SNY) Investor Outlook: A Strong Buy with 23.72% Potential Upside

Sanofi (SNY), a titan in the healthcare sector, particularly within the general drug manufacturing industry, is garnering attention from investors due to its promising growth potential..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Play with a 41.55% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK), with a market capitalization of $7.73 billion, operates in the dynamic biotechnology industry within the healthcare sector. This late-stage biopharmaceutical company is..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 11.17% Upside in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, has been making waves with its innovative solutions for ophthalmic diseases...

Exact Sciences Corporation (EXAS) Stock Analysis: Steady Growth in Diagnostics Sector with 3.39% Potential Upside

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the diagnostics and research sector, has attracted significant investor attention as its current stock price hovers at $102.34,..

The Ensign Group, Inc. (ENSG) Stock Analysis: Robust Growth and a 21% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 9.71% Potential Upside in the Healthcare Giant

AstraZeneca PLC (NASDAQ: AZN), a colossus in the global biopharmaceutical landscape, continues to captivate investors with its solid performance and strategic collaborations. With a market capitalization..

ResMed Inc. (RMD) Stock Analysis: A Strong Performer with 15% Upside Potential

ResMed Inc. (NYSE: RMD) is a major player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $37.7..

Repligen Corporation (RGEN) Stock Analysis: Navigating a 27.80% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) is garnering significant attention in the healthcare sector, specifically within the medical instruments and supplies industry. The company, headquartered in Waltham, Massachusetts,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential Amidst Robust Revenue Surge in Medical Devices

TransMedics Group, Inc. (NASDAQ: TMDX), a leader in the medical devices sector, is capturing the interest of investors with its innovative approach to organ transplant therapy...

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Tapping into a 43% Potential Upside in the Healthcare Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. Based in San Francisco, this medical device..

Exelixis, Inc. (EXEL) Stock Analysis: Insights on Growth Potential and Market Position

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its focus on developing innovative oncology treatments. With a market capitalization..

Alkermes plc (ALKS) Stock Analysis: Navigating a 29% Potential Upside in the Biopharmaceutical Sector

Alkermes plc (NASDAQ: ALKS) stands out as a noteworthy player in the healthcare arena, specializing in the development and commercialization of pharmaceutical products that address significant..

Natera, Inc. (NTRA) Stock Analysis: Potential Growth Amidst Strong Analyst Confidence

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry, is drawing significant attention in the healthcare sector. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds